Table of Contents Author Guidelines Submit a Manuscript
Minimally Invasive Surgery
Volume 2011, Article ID 724635, 4 pages
http://dx.doi.org/10.1155/2011/724635
Research Article

In Vitro Antimicrobial Susceptibility of Mycobacterium massiliense Recovered from Wound Samples of Patients Submitted to Arthroscopic and Laparoscopic Surgeries

Departamento de Microbiologia, Imunologia, Parasitologia e Patologia, Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Rua Delenda Rezende Melo com 1a Avenida, S/No, Setor Universitário, Goiânia, 74605-050 Goiás, Brazil

Received 14 September 2010; Accepted 26 November 2010

Academic Editor: Kristi L. Harold

Copyright © 2011 Alessandra Marques Cardoso et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Testing of rapidly growing species of mycobacteria (RGM) against antibacterial agents has been shown to have some clinical utility. This work establishes the MICs of seven antimicrobial agents following the guidelines set forth by the Clinical and Laboratory Standards Institute (CLSI) against eighteen isolates of Mycobacterium massiliense recovered from wound samples of patients submitted to minimally invasive surgery such as arthroscopy and laparoscopy. The isolates showed susceptibility to amikacin ( μg/mL) and clarithromycin ( μg/mL) but resistance to ciprofloxacin ( μg/mL), doxycycline ( μg/mL), sulfamethoxazole ( μg/mL), and tobramycin ( μg/mL), and intermediate profile to cefoxitin ( μg/mL). Therefore, we suggest that the antimicrobial susceptibilities of any clinically significant RGM isolate should be performed.